Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction

被引:10
作者
Choi, Jonggi [1 ]
Lim, Young-Suk [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Liver Ctr, Dept Gastroenterol, 88 Olymp Ro 43 Gil, Ulsan 05505, South Korea
关键词
EFFICACY;
D O I
10.1016/j.jhep.2019.06.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:846 / 847
页数:3
相关论文
共 10 条
[1]   RETRACTED: Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study (Retracted Article) [J].
Choi, Jonggi ;
Kim, Hyo Jeong ;
Lee, Jayoun ;
Cho, Songhee ;
Ko, Min Jung ;
Lim, Young-Suk .
JAMA ONCOLOGY, 2019, 5 (01) :30-36
[2]   Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B One of These Things Is Not Like the Other [J].
Flemming, Jennifer A. ;
Terrault, Norah A. .
JAMA ONCOLOGY, 2019, 5 (01) :17-18
[3]   Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis [J].
Jang, Jeong Won ;
Choi, Jong Young ;
Kim, Young Seok ;
Woo, Hyun Young ;
Choi, Sung Kyu ;
Lee, Chang Hyeong ;
Kim, Tae Yeob ;
Sohn, Joo Hyun ;
Tak, Won Young ;
Han, Kwang-Hyub .
HEPATOLOGY, 2015, 61 (06) :1809-1820
[4]   Mortality, liver transplantation and hepatic complications in patients with treatment-naive chronic hepatitis B treated with entecavir vs tenofovir [J].
Kim, Byung Gyu ;
Park, Neung Hwa ;
Lee, Seung Bum ;
Lee, Hojune ;
Lee, Byung Uk ;
Park, Jae Ho ;
Jung, Seok Won ;
Jeong, In Du ;
Bang, Sung-Jo ;
Shin, Jung Woo .
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (12) :1565-1575
[5]   A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea [J].
Kim, Seung Up ;
Seo, Yeon Seok ;
Lee, Han Ah ;
Kim, Mi Na ;
Lee, Yu Rim ;
Lee, Hye Won ;
Park, Jun Yong ;
Kim, Do Young ;
Ahn, Sang Hoon ;
Han, Kwang-Hyub ;
Hwang, Seong Gyu ;
Rim, Kyu Sung ;
Um, Soon Ho ;
Tak, Won Young ;
Kweon, Young Oh ;
Kim, Beom Kyung ;
Park, Soo Young .
JOURNAL OF HEPATOLOGY, 2019, 71 (03) :456-464
[6]  
Kim YM, 2018, SAUDI J GASTROENTERO, V24, P326, DOI [10.4103/sjg.SJG_49_18, 10.4103/sjg.sjg_49_18]
[7]   Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis [J].
Koklu, Seyfettin ;
Tuna, Yasar ;
Gulsen, Murat Taner ;
Demir, Mehmet ;
Koksal, Aydin Seref ;
Kockar, Muhammet Cem ;
Aygun, Cem ;
Coban, Sahin ;
Ozdil, Kamil ;
Ataseven, Huseyin ;
Akin, Ebru ;
Purnak, Tugrul ;
Yuksel, Ilhami ;
Ataseven, Hilmi ;
Ibis, Mehmet ;
Yildirim, Beytullah ;
Nadir, Isilay ;
Kucukazman, Metin ;
Akbal, Erdem ;
Yuksel, Osman ;
Basar, Omer ;
Alkan, Erhan ;
Baykal, Ozlem .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (01) :88-94
[8]   Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis [J].
Shim, Ju Hyun ;
Lee, Han Chu ;
Kim, Kang Mo ;
Lim, Young-Suk ;
Chung, Young-Hwa ;
Lee, Yung Sang ;
Suh, Dong Jin .
JOURNAL OF HEPATOLOGY, 2010, 52 (02) :176-182
[9]   Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B [J].
Yip, Terry C. F. ;
Wong, Vincent Wai-Sun ;
Tse, Yee-Kit ;
Chan, Henry ;
Wong, Grace Lai-Hung .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :E128-E128
[10]   The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis [J].
Zhang, Zeyu ;
Zhou, Yufan ;
Yang, Jiajin ;
Hu, Kuan ;
Huang, Yun .
BMC CANCER, 2019, 19 (1)